Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP590771.RArWwz1S3xZ1mHqWaThgCWj2nMm0nj8hvvR78l4P9FXwE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP590771.RArWwz1S3xZ1mHqWaThgCWj2nMm0nj8hvvR78l4P9FXwE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP590771.RArWwz1S3xZ1mHqWaThgCWj2nMm0nj8hvvR78l4P9FXwE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP590771.RArWwz1S3xZ1mHqWaThgCWj2nMm0nj8hvvR78l4P9FXwE130_provenance.
- NP590771.RArWwz1S3xZ1mHqWaThgCWj2nMm0nj8hvvR78l4P9FXwE130_assertion description "[The recently described JAK2 V617F mutation, present in a substantial proportion of nonchronic myelogenous leukemia chronic myeloproliferative disorders (non-CML CMPDs), is changing the way we conceptualize and diagnose these diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP590771.RArWwz1S3xZ1mHqWaThgCWj2nMm0nj8hvvR78l4P9FXwE130_provenance.
- NP590771.RArWwz1S3xZ1mHqWaThgCWj2nMm0nj8hvvR78l4P9FXwE130_assertion evidence source_evidence_literature NP590771.RArWwz1S3xZ1mHqWaThgCWj2nMm0nj8hvvR78l4P9FXwE130_provenance.
- NP590771.RArWwz1S3xZ1mHqWaThgCWj2nMm0nj8hvvR78l4P9FXwE130_assertion SIO_000772 17255768 NP590771.RArWwz1S3xZ1mHqWaThgCWj2nMm0nj8hvvR78l4P9FXwE130_provenance.
- NP590771.RArWwz1S3xZ1mHqWaThgCWj2nMm0nj8hvvR78l4P9FXwE130_assertion wasDerivedFrom befree-2016 NP590771.RArWwz1S3xZ1mHqWaThgCWj2nMm0nj8hvvR78l4P9FXwE130_provenance.
- NP590771.RArWwz1S3xZ1mHqWaThgCWj2nMm0nj8hvvR78l4P9FXwE130_assertion wasGeneratedBy ECO_0000203 NP590771.RArWwz1S3xZ1mHqWaThgCWj2nMm0nj8hvvR78l4P9FXwE130_provenance.
- befree-2016 importedOn "2016-02-19" NP590771.RArWwz1S3xZ1mHqWaThgCWj2nMm0nj8hvvR78l4P9FXwE130_provenance.